BRITTANY HARRISON: Open Payments
NPI 1669862280 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 27 payments from 8 companies in 2025. Trend: 2023 $235 · 2024 $333 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $137 |
| ABBVIE INC. | 5 | $111 |
| Supernus Pharmaceuticals, Inc. | 3 | $104 |
| Alkermes, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, INVEGA, Qelbree, REXULTI, FANAPT, ARISTADA, SPRAVATO, COBENFY.
Industry payments across LA — which companies pay providers there.
